EU medtech: 'Heavy-handed notified bodies going too far'
This article was originally published in SRA
Executive Summary
Medical device companies in the EU are being caught out during routine audits by notified bodies who are treating as law recommendations aimed among other things at improving the way in which such audits are conducted. Regulatory intervention has gone too far and is disproportionate to the risk involved, it is being argued.